60 DEGREES PHARMACEUTICALS, INC.

Nasdaq:SXTPNasdaq:SXTPW

Pharmaceutical Preparations·WASHINGTON, DC

CEO

Dow Geoffrey S

Financials

10 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

News (8-K)

35 shown

Filed	Type	Description
2/12/26	Other	Other Events	→
1/23/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/21/26	Other	Amendments to Articles of Incorporation or Bylaws	→
1/8/26	Reg FD	Regulation FD Disclosure	→
10/10/25	Vote	Submission of Matters to a Vote of Security Holders	→
9/9/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

23 shown

Filed	Form	Description
3/2/26	424B5	PROSPECTUS SUPPLEMENT	→
9/5/25	424B5	PROSPECTUS SUPPLEMENT	→
7/16/25	424B4	424B4	→
7/7/25	S-1	REGISTRATION STATEMENT	→
3/27/25	S-1/A	AMENDMENT NO. 1 TO FORM S-1	→
2/14/25	S-1	REGISTRATION STATEMENT	→
↓

Filing History(190 filings)

TypeDateAccessionPeriodSize

424B5

Mar 2, 2026

0001213900-26-022325PROSPECTUS SUPPLEMENT

—

19.9 KB

8-K

Feb 12, 2026

0001213900-26-015239CURRENT REPORT

Feb 11, 2026

233.4 KB

8-K

Jan 23, 2026

0001213900-26-007330CURRENT REPORT

Jan 20, 2026

235.2 KB

8-K

Jan 21, 2026

0001213900-26-006179CURRENT REPORT

Jan 14, 2026

2.3 MB

8-K

Jan 8, 2026

0001213900-26-002359CURRENT REPORT

Jan 8, 2026

16.9 MB

Dec 16, 2025

0001213900-25-122379

Dec 15, 2025

4.5 KB

Dec 12, 2025

0001213900-25-120948OWNERSHIP DOCUMENT

Dec 10, 2025

6.0 KB

SCHEDULE 13G/A

Nov 13, 2025

0001493152-25-022267

—

11.7 KB

10-Q

Nov 13, 2025

0001554855-25-00203210-Q

Sep 30, 2025

8.9 MB

SCHEDULE 13G/A

Nov 7, 2025

0001213900-25-107730

—

14.0 KB

SCHEDULE 13G/A

Nov 7, 2025

0001649553-25-000204

—

11.6 KB

8-K

Oct 10, 2025

0001213900-25-098131CURRENT REPORT

Oct 8, 2025

253.0 KB

Sep 15, 2025

0001213900-25-087681

Sep 12, 2025

5.6 KB

8-K

Sep 9, 2025

0001213900-25-085853CURRENT REPORT

Sep 9, 2025

7.1 MB

424B5

Sep 5, 2025

0001213900-25-085050PROSPECTUS SUPPLEMENT

—

1.0 MB

8-K

Sep 5, 2025

0001213900-25-085040CURRENT REPORT

Sep 3, 2025

507.5 KB

DEFR14A

Sep 2, 2025

0001213900-25-082789DEFINITIVE PROXY STATEMENT

—

2.9 MB

DEF 14A

Aug 27, 2025

0001213900-25-080878DEFINITIVE PROXY STATEMENT

Oct 8, 2025

954.9 KB

PRE 14A

Aug 15, 2025

0001213900-25-077435PRELIMINARY PROXY STATEMENT

Aug 15, 2025

582.0 KB

Aug 14, 2025

0001213900-25-076984

Sep 26, 2024

5.9 KB

Aug 14, 2025

0001213900-25-076983

Jan 17, 2025

4.9 KB

Aug 14, 2025

0001213900-25-076982

Feb 12, 2024

3.1 KB

10-Q

Aug 13, 2025

0001554855-25-00100910-Q

Jun 30, 2025

8.2 MB

SCHEDULE 13G

Jul 22, 2025

0001649553-25-000133

—

15.6 KB

SCHEDULE 13G

Jul 18, 2025

0001213900-25-065799

—

23.7 KB

25 filings shown

60 DEGREES PHARMACEUTICALS, INC.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(190 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
9/2/25	DEFR14A	DEFINITIVE PROXY STATEMENT	→
8/27/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
8/15/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
10/15/24	DEF 14A	DEF 14A	→
10/2/24	PRE 14A	PRE 14A	→
5/30/24	DEF 14A	DEFINITIVE PROXY STATEMENT	→
↓

Filed	Form	Description
12/16/25	4	4	→
12/12/25	4	OWNERSHIP DOCUMENT	→
9/15/25	4	4	→
8/14/25	4	4	→
8/14/25	4	4	→
8/14/25	3	3	→
↓